Stingray Therapeutics has filed a notice of an exempt offering of securities to raise $5,230,297.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Stingray Therapeutics is raising $5,230,297.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jonathan Northrup played a key role…
